Nutritional support teams increase percutaneous endoscopic gastrostomy uptake in motor neuron disease

Table 2 Relationship between the uptake of percutaneous endoscopic gastrostomy and clinician initiating discussion

	Nutritional support team	Other clinicians	P value
Initial PEG discussions, n	36	29
Patients undergoing PEG insertion after initial discussion, n	20 (56%, 20/36)	7 (24%, 7/29)	0.011
MND symptom onset to MND diagnosis, mo	12.8 (± 7.5), n = 26	8.4 (± 3.9), n = 17	0.017
MND diagnosis to initial PEG discussion, mo	5.4 (± 7.0), n = 20	11.9 (± 13.4), n = 6	0.028
Initial PEG discussion to placement, mo	3.5 (± 3.3), n = 20	4.4 (± 3.2), n = 6	0.572
PEG placement to death, mo	12.9 (± 11.1), n = 20	8.8 (± 10.1), n = 6	0.422
MND symptom onset to death, mo	30.0 (± 13.2), n = 26	31.2 (± 13.2), n = 17	0.740
MND diagnosis to death, mo	18.0 (± 15.6), n = 36	21.6 (± 15.6), n = 27	0.393

MND: Motor neuron disease; PEG: Percutaneous endoscopic gastrostomy.